These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36680843)

  • 1. Five negative symptom domains are differentially associated with resting state amplitude of low frequency fluctuations in Schizophrenia.
    Cheon EJ; Male AG; Gao B; Adhikari BM; Edmond JT; Hare SM; Belger A; Potkin SG; Bustillo JR; Mathalon DH; Ford JM; Lim KO; Mueller BA; Preda A; O'Leary D; Strauss GP; Ahmed AO; Thompson PM; Jahanshad N; Kochunov P; Calhoun VD; Turner JA; van Erp TGM
    Psychiatry Res Neuroimaging; 2023 Mar; 329():111597. PubMed ID: 36680843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.
    Ahmed AO; Kirkpatrick B; Granholm E; Rowland LM; Barker PB; Gold JM; Buchanan RW; Outram T; Bernardo M; Paz García-Portilla M; Mane A; Fernandez-Egea E; Strauss GP
    Schizophr Bull; 2022 May; 48(3):620-630. PubMed ID: 35020936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of negative symptoms on health-related quality of life in schizophrenia.
    Li Y; Rekhi G; Ang MS; Lee J
    Front Psychiatry; 2023; 14():1252354. PubMed ID: 37744001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders.
    Guessoum SB; Le Strat Y; Dubertret C; Mallet J
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109862. PubMed ID: 31927053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
    Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Brief Negative Symptom Scale and its association with functioning.
    Ang MS; Rekhi G; Lee J
    Schizophr Res; 2019 Jun; 208():97-104. PubMed ID: 30987926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual negative symptoms and domains - Relevance for assessment, pathomechanisms and treatment.
    Kaiser S; Lyne J; Agartz I; Clarke M; Mørch-Johnsen L; Faerden A
    Schizophr Res; 2017 Aug; 186():39-45. PubMed ID: 27453425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between dissociative symptoms and schizophrenia-related negative symptoms: A transdiagnostic approach.
    Levin Y; Bachem R; Brafman D; Ben-Ezra M
    J Psychiatr Res; 2024 Jan; 169():81-83. PubMed ID: 38006822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development.
    Strauss GP; Bartolomeo LA; Harvey PD
    NPJ Schizophr; 2021 Feb; 7(1):16. PubMed ID: 33637748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disrupted amplitude of low-frequency fluctuations in antipsychotic-naïve adolescents with early-onset schizophrenia.
    Zheng J; Zhang Y; Guo X; Duan X; Zhang J; Zhao J; Chen H
    Psychiatry Res Neuroimaging; 2016 Mar; 249():20-6. PubMed ID: 27000303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vocational Profile and Correlates of Employment in People With Schizophrenia: The Role of Avolition.
    Ang MS; Rekhi G; Lee J
    Front Psychiatry; 2020; 11():856. PubMed ID: 33192630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it more effective for anhedonia and avolition? A systematic review and meta-analysis of non-invasive brain stimulation interventions for negative symptoms in schizophrenia.
    Chen Y; Li Z; Yan C; Zou L
    CNS Neurosci Ther; 2024 Mar; 30(3):e14645. PubMed ID: 38432851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.
    Strauss GP; Esfahlani FZ; Kirkpatrick B; Allen DN; Gold JM; Visser KF; Sayama H
    Schizophr Bull; 2019 Oct; 45(6):1319-1330. PubMed ID: 30649527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.
    Neill JC; Harte MK; Haddad PM; Lydall ES; Dwyer DM
    Eur Neuropsychopharmacol; 2014 May; 24(5):822-35. PubMed ID: 24287012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing Links Between Early Auditory Information Processing and Negative Symptoms in Schizophrenia: An ERP Study.
    Giordano GM; Brando F; Perrottelli A; Di Lorenzo G; Siracusano A; Giuliani L; Pezzella P; Altamura M; Bellomo A; Cascino G; Del Casale A; Monteleone P; Pompili M; Galderisi S; Maj M;
    Front Psychiatry; 2021; 12():790745. PubMed ID: 34987433
    [No Abstract]   [Full Text] [Related]  

  • 20. The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.
    Chang WC; Strauss GP; Ahmed AO; Wong SCY; Chan JKN; Lee EHM; Chan SKW; Hui CLM; James SH; Chapman HC; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):386-394. PubMed ID: 32909606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.